Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients
This study is currently recruiting participants.
Verified March 2013 by Grifols Biologicals Inc.
Sponsor:
Grifols Biologicals Inc.
Information provided by (Responsible Party):
Grifols Biologicals Inc.
ClinicalTrials.gov Identifier:
NCT00555555
First received: November 7, 2007
Last updated: March 18, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2017 |
| Estimated Primary Completion Date: | December 2016 (Final data collection date for primary outcome measure) |